心脏衰竭与保存的喷射分数
Amir Barzin1, Kathleen K Barnhouse2, Shawn F Kane2
1University of North Carolina School of Medicine, Chapel Hill.
American family physician
|October 21, 2025
概括
保持喷射分数 (HFpEF) 的心力衰竭很常见,并呈现出和呼吸障碍等症状. -葡萄糖共传输体-2 抑制剂可以降低高血压患者的住院和死亡率.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
背景情况:
- 保存喷射分数 (HFpEF) 的心力衰竭是最常见的心力衰竭类型,影响到10%的成年人.
- HFpEF的特点是心室填充和排气受损,导致心脏输出减少.
- 症状包括周围,呼吸不全,骨质疏松,状静脉张张,以及特定的心声回声检查结果.
研究的目的:
- 概述了心力衰竭的诊断和管理,并保留了喷射分数.
- 突出特定药物在管理HFpEF中的作用.
- 强调在HFpEF治疗中考虑-葡萄糖共运输体-2 抑制剂的重要性.
主要方法:
- 诊断包括临床表现,实验室值 (例如,益激素脑性尿素的N端片段升高) 和心声回声.
- 管理重点在于治疗并发性疾病,如高血压,肥胖和阻塞性睡眠呼吸暂停.
- 药理疗法包括-葡萄糖携运输体-2 抑制剂,循环利尿剂,矿物质皮质类受体对抗剂和血管激素受体阻断剂/内普利辛抑制剂.
主要成果:
- 在符合条件的患者中,-葡萄糖共传输体-2 抑制剂表明心力衰竭住院和心血管死亡率有所降低.
- 既有药物,如循环利尿剂,矿物质皮质类受体对抗剂和ARNI/ARB也被使用.
- 建议在耐火性病例或末端器官功能障碍时咨询心力衰竭专家.
结论:
- 早期诊断和管理HFpEF对于改善患者的治疗结果至关重要.
- -葡萄糖共传输体-2 抑制剂代表了HFpEF药物治疗的重大进展.
- 多学科的方法,包括必要时的专家咨询,优化HFpEF护理.
相关概念视频
Pathophysiology of Heart Failure
2.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.6K
Heart Failure IV: Classification and Diagnostic Evaluation
281
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
281
Heart Failure II: Pathophysiology
658
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
658
Heart Failure I: Introduction
653
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
653
Heart Failure III: Clinical Manifestations
430
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
430
Heart Failure V: Medical Management
195
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
195


